Voltage-gated sodium channels
Assets acting on this target.
- Class
- Antiseizure drug
- Notes
- audit finding #325 (minor); source: https://api.fda.gov/drug/label.json?search=openfda.brand_name:ZONEGRAN
By indication
Related mechanisms
Voltage-gated sodium channel (7)Voltage-gated sodium channels; GABA-A receptor; AMPA/kainate glutamate receptors; carbonic anhydrase (5)Voltage-gated sodium channel NaV1.8 (3)α2δ-1 subunit of voltage-gated calcium channels (2)α2δ subunit of voltage-gated calcium channels (2)Voltage-gated potassium channel (Kv) (1)
Voltage-gated sodium channels drugs compared
3 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| LacosamideVimpat | UCB | small molecule | Approved | Approved in Epilepsy; Approved in Focal Onset Seizures; Approved in Primary Generalized Tonic-Clonic Seizures |
| Phenytoin | Viatris | small molecule | Approved | Approved in Epilepsy |
| Zonisamide (Zonegran)Zonegran | Advanz Pharma, Eisai | small molecule | Approved | Approved in Epilepsy |